Page last updated: 2024-08-17

carbostyril and Pneumonia, Bacterial

carbostyril has been researched along with Pneumonia, Bacterial in 47 studies

Research

Studies (47)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	17 (36.17)	18.2507
2000's	13 (27.66)	29.6817
2010's	15 (31.91)	24.3611
2020's	2 (4.26)	2.80

Authors

Authors	Studies
Asai, K; Hino, M; Hirose, A; Imoto, W; Kakeya, H; Kaneko, Y; Kawaguchi, T; Koh, H; Nakaie, K; Nakamae, H; Namikawa, H; Shibata, W; Watanabe, T; Yamada, K; Yamairi, K; Yoshii, N; Yukawa, S	1
Peters, AT; Pickens, CI; Postelnick, MJ; Qi, C; Wunderink, RG; Zembower, TR	1
Mikamo, H; Mitsuyama, J; Nakagawa, S; Nomura, N; Shibata, T; Yamagishi, Y	1
Fujimura, S; Furukawa, E; Kawamura, M; Nakai, H; Sato, T; Takahashi, H; Uno, T; Watanabe, A	1
Cao, Z; Chang, L; Cheng, SL; Lv, Y; Ma, Z; Mo, B; Sun, S; Tong, Z; Wu, J; Wu, R; Yang, Y; Yuan, J; Zhang, Y; Zhu, D	1
Adriaenssens, N; Bartholomeeusen, S; Coenen, S; Ryckebosch, P	1
Chen, YH; Hsueh, PR; Huang, CH; Lai, CC	1
An, X; Chen, J; Fu, K; Huang, Y; Kang, H; Mi, Z; Pei, G; Peng, F; Tong, Y; Wang, W; Wang, Y; Xu, X; Yin, X; Zhang, X; Zhang, Z; Zhou, L	1
Cao, Z; Chang, L; Chen, P; Cui, S; Hu, C; Kuang, J; Li, J; Liang, Y; Liu, H; Liu, S; Liu, Y; Lv, X; Lv, Y; Ren, Z; Sun, S; Wang, C; Wang, D; Wang, X; Wu, J; Xiao, Z; Xiu, Q; Yang, H; Zhang, Y; Zhao, L; Zhu, D	1
Arriaga, I; Bilbao, A; Camino, J; Capelastegui, A; España, PP; Intxausti, M; Lobo, JL; Nuñez, J; Quintana, JM; Tomás, L; Uranga, A	1
Torres, A	1
Gillissen, A; Häussermann, A	1
Fujita, M; Ishikura, H; Kitamura, T; Matsumoto, T; Toyoshima, H; Watanabe, K; Yoshimura, C	1
Greub, G; Lamoth, F	1
Bai, L; Cao, B; Gonzalez, R; Guo, P; Liu, YM; Ren, LL; Song, SF; Wang, C; Wang, JW; Yin, YD; Zhang, JZ; Zhang, YY; Zhao, F	1
De Waele, JJ; Deja, M; Diaz, E; Guven, M; Koulenti, D; Lisboa, T; Mañez, R; Martin-Loeches, I; Putensen, C; Rello, J; Ulldemolins, M	1
Cen, S; Huang, P; Jiang, JD; Li, CR; Li, GQ; Li, Y; Liu, JF; Lou, RH; Yang, XY; You, XF; Yu, LY; Yuan, M; Zhang, WX; Zhao, LX	1
Eliakim-Raz, N; Lador, A; Leibovici, L; Paul, M; Skalsky, K; Yahav, D	1
Anderson, L; Boucher, R; Collier, DN; Gilligan, P; Knowles, M; McKnight, SL; Noah, TL; Pesci, EC; Schwab, U	1
Hammerschlag, MR; Reznik, T; Roblin, PM	1
Hammerschlag, MR	1
Cunha, BA	1
Kollef, MH; Shorr, AF; Susla, GB	1
Greub, G; Hammerschlag, MR; Senn, L	1
Fuchigami, T; Kaku, M; Kuwabara, M; Rikitomi, N; Totsuka, K	1
Cremades Romero, MJ; Martínez Moragón, E; Martínez Tomas, R; Menéndez Villanueva, R; Reyes Calzada, S; Soler Cataluña, JJ	1
Asche, C; Crookston, B; McAdam-Marx, C; Mullins, CD; Seal, B	1
Hattori, H; Nakamura, S; Nakata, K; Okazaki, Y	1
Brumpt, I; Grassi, GG	1
Lochmann, O; Vyhnánek, F	1
Garau, J; Grassi, C; Hosie, J; Huchon, G; Legakis, N; Lode, H; Segev, S; Wijnands, G	1
Ibuki, E; Masuda, N; Miyoshi, H; Nishino, T; Otsuki, M; Takahashi, Y	1
Aubier, M; Gialdroni-Grassi, G; Hosie, J; Huchon, G; Legakis, N; Lode, H; Regamey, C; Segev, S; Tolstuchow, N; Vester, R; Wijnands, WJ	1
May, T; Portier, H; Proust, A	1
Rubinstein, E	1
Cars, O; Jean, C; Ortqvist, A; Saikku, P; Valtonen, M; Wahl, M	1
Kishimoto, T; Matsushima, T; Miyashita, N; Nakajima, M; Niki, Y	1
De Reske, M; Delaney, K; Fletch, A; Kinlough-Rathbone, RL; Richardson, M; Wilcox, LH	1
Dutchman, DA; Maroli, A; O'Doherty, B; Pettit, R	1
Iakovlev, SV	1
Ramirez, J; Talbot, GH; Townsend, L; Unowsky, J; Zhang, H	1
Dorr, MB; Lipsky, BA; Magner, DJ; Talbot, GH	1
Barberán, J; Gomis, M; Ledesma, F; Sánchez, B	1
Belousov, IuB; Efremenkova, OV; Sokolov, AV; Tishenkova, IF	1
Fodor, L; Hodge, A; Reeve-Johnson, L; Varga, J	1
Brownstein, DG; Compton, SR; Macy, JD; Shlomchik, MJ; Weir, EC	1
Knirsch, C; Luchsinger, JA; Pablos-Méndez, A; Rabinowitz, D; Shea, S	1

Reviews

10 review(s) available for carbostyril and Pneumonia, Bacterial

Article	Year
The potential role of nemonoxacin for treatment of common infections. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:2 Topics: Anti-Bacterial Agents; Chlamydia Infections; Clostridium Infections; Community-Acquired Infections; Drug Therapy, Combination; Gonorrhea; Humans; Levofloxacin; Pneumonia, Bacterial; Quinolones; Skin Diseases, Bacterial	2015
[Diseases of the lung and air passages 2010]. Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:25-26 Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aminopyridines; Asthma; Benzamides; Cyclopropanes; Drug Therapy, Combination; Humans; Hypertension, Pulmonary; Indans; Lung Diseases; Lung Neoplasms; Neoplasm Staging; Phosphodiesterase 4 Inhibitors; Pneumonia, Bacterial; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Quinolones	2010
Fastidious intracellular bacteria as causal agents of community-acquired pneumonia. Expert review of anti-infective therapy, 2010, Volume: 8, Issue:7 Topics: Bacteria; Community-Acquired Infections; Humans; Macrolides; Pneumonia, Bacterial; Quinolones	2010
Macrolides vs. quinolones for community-acquired pneumonia: meta-analysis of randomized controlled trials. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2013, Volume: 19, Issue:4 Topics: Adult; Anti-Bacterial Agents; Community-Acquired Infections; Drug-Related Side Effects and Adverse Reactions; Humans; Macrolides; Pneumonia, Bacterial; Quinolones; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Failure	2013
Pneumonia due to Chlamydia pneumoniae in children: epidemiology, diagnosis, and treatment. Pediatric pulmonology, 2003, Volume: 36, Issue:5 Topics: Adolescent; Anti-Bacterial Agents; Antibodies, Bacterial; Child; Child, Preschool; Chlamydophila Infections; Chlamydophila pneumoniae; DNA, Bacterial; Humans; Infant; Infant, Newborn; Macrolides; Pneumonia, Bacterial; Quinolones; Sensitivity and Specificity; Tetracyclines	2003
Empiric therapy of community-acquired pneumonia: guidelines for the perplexed? Chest, 2004, Volume: 125, Issue:5 Topics: Administration, Oral; Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Bacterial; Hospitalization; Humans; Macrolides; Pneumonia, Bacterial; Practice Guidelines as Topic; Quinolones; Severity of Illness Index	2004
Quinolones for treatment of nosocomial pneumonia: a meta-analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Feb-15, Volume: 40 Suppl 2 Topics: Anti-Infective Agents; Cilastatin; Ciprofloxacin; Cross Infection; Humans; Imipenem; Levofloxacin; Meta-Analysis as Topic; Ofloxacin; Pneumonia, Bacterial; Quinolones; Randomized Controlled Trials as Topic	2005
Therapeutic approaches to Chlamydia infections. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:13 Topics: Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Conjunctivitis, Inclusion; Female Urogenital Diseases; Humans; Macrolides; Pneumonia, Bacterial; Practice Guidelines as Topic; Quinolones; Randomized Controlled Trials as Topic; Tetracyclines; Trachoma	2005
Sparfloxacin empirical therapy in community-acquired pneumonia. Results of a meta-analysis of 2 comparative studies. Drugs, 1995, Volume: 49 Suppl 2 Topics: Adult; Anti-Infective Agents; Community-Acquired Infections; Fluoroquinolones; Humans; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Quinolones; Treatment Outcome	1995
[Has the moment arrived for quinolones in the treatment of respiratory infections?]. Enfermedades infecciosas y microbiologia clinica, 1998, Volume: 16 Suppl 2 Topics: Community-Acquired Infections; Humans; Pneumonia, Bacterial; Quinolones; Respiratory Tract Infections	1998

Trials

13 trial(s) available for carbostyril and Pneumonia, Bacterial

Article	Year
Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2019, Volume: 52, Issue:1 Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Community-Acquired Infections; Double-Blind Method; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Microbial Viability; Middle Aged; Pneumonia, Bacterial; Quinolones; Safety; Treatment Outcome	2019
A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2017, Volume: 50, Issue:6 Topics: Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Double-Blind Method; Female; Haemophilus influenzae; Humans; Levofloxacin; Male; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Bacterial; Quinolones; Streptococcus pneumoniae; Treatment Outcome; Young Adult	2017
Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial. JAMA internal medicine, 2016, 09-01, Volume: 176, Issue:9 Topics: Aged; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Community-Acquired Infections; Drug Administration Schedule; Female; Hospitalization; Hospitals, Teaching; Humans; Macrolides; Male; Middle Aged; Patient Readmission; Pneumonia, Bacterial; Quinolones; Severity of Illness Index; Spain	2016
Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin. The European respiratory journal, 1995, Volume: 8, Issue:12 Topics: Adolescent; Adult; Aged; Amoxicillin; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Gastrointestinal Diseases; Humans; Male; Middle Aged; Pneumonia, Bacterial; Quinolones; Treatment Failure	1995
Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies. The Journal of antimicrobial chemotherapy, 1996, Volume: 37 Suppl A Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Penicillins; Pneumonia, Bacterial; Quinolones; Streptococcus pneumoniae	1996
Comparative efficacy of sparfloxacin in comparison with amoxycillin plus ofloxacin in the treatment of community-acquired pneumonia. French Study Group. The Journal of antimicrobial chemotherapy, 1996, Volume: 37 Suppl A Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Ofloxacin; Penicillins; Pneumonia, Bacterial; Quinolones	1996
Safety profile of sparfloxacin in the treatment of respiratory tract infections. The Journal of antimicrobial chemotherapy, 1996, Volume: 37 Suppl A Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Pneumonia, Bacterial; Quinolones; Randomized Controlled Trials as Topic; Respiratory Tract Infections	1996
Oral empiric treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing sparfloxacin with roxithromycin. The Scandinavian Sparfloxacin Study Group. Chest, 1996, Volume: 110, Issue:6 Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pneumonia, Bacterial; Quinolones; Roxithromycin	1996
Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia. The Journal of antimicrobial chemotherapy, 1997, Volume: 40 Suppl A Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Bacteria; Community-Acquired Infections; Double-Blind Method; Female; Fluoroquinolones; Hematologic Tests; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Patient Dropouts; Penicillins; Piperazines; Pneumonia, Bacterial; Quinolones; Treatment Outcome	1997
[Pharmacodynamic and pharmacokinetic approaches to optimization of lomefloxacin]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1998, Volume: 43, Issue:10 Topics: Age Factors; Aged; Anti-Infective Agents; Bronchitis; Chronic Disease; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Quinolones; Streptococcus pneumoniae	1998
Sparfloxacin versus clarithromycin in the treatment of community-acquired pneumonia. Clinical therapeutics, 1999, Volume: 21, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pneumonia, Bacterial; Quinolones	1999
[The importance of fluoroquinolones in treating pneumonia in the elderly]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1999, Volume: 44, Issue:12 Topics: Aged; Anti-Infective Agents; Bronchitis; Chronic Disease; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Quinolones; Sputum; Time Factors	1999
Efficacy evaluations of the use of oral tilmicosin in pneumonic calves. Veterinary journal (London, England : 1997), 2000, Volume: 159, Issue:2 Topics: Administration, Oral; Animals; Animals, Newborn; Anti-Bacterial Agents; Anti-Infective Agents; Cattle; Cattle Diseases; Enrofloxacin; Female; Fluoroquinolones; Macrolides; Male; Pneumonia, Bacterial; Quinolones; Treatment Outcome; Tylosin	2000

Other Studies

24 other study(ies) available for carbostyril and Pneumonia, Bacterial

Article	Year
Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia. Internal medicine (Tokyo, Japan), 2020, Volume: 59, Issue:2 Topics: Adult; Female; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Hemoptysis; Hemorrhage; Humans; Immunocompromised Host; Male; Middle Aged; Pneumonia, Bacterial; Prognosis; Quinolones; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Thrombocytopenia; Trimethoprim, Sulfamethoxazole Drug Combination	2020
Decreasing incidence of Infection control and hospital epidemiology, 2022, Volume: 43, Issue:9 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Incidence; Pneumonia, Bacterial; Quinolones; Retrospective Studies; Vancomycin	2022
Proposed Pharmacokinetic-Pharmacodynamic Breakpoint of Garenoxacin and Other Quinolones. Japanese journal of infectious diseases, 2017, Nov-22, Volume: 70, Issue:6 Topics: Administration, Oral; Anti-Bacterial Agents; Area Under Curve; Community-Acquired Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Pneumonia, Bacterial; Quinolones; Streptococcus pneumoniae	2017
Mutant selection window of four quinolone antibiotics against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018, Volume: 24, Issue:2 Topics: Anti-Bacterial Agents; DNA Gyrase; DNA Mutational Analysis; DNA Topoisomerase IV; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Otitis Media; Pneumonia, Bacterial; Quinolones; Selection, Genetic; Streptococcus pneumoniae	2018
Quality of antibiotic prescription during office hours and out-of-hours in Flemish primary care, using European quality indicators. The European journal of general practice, 2014, Volume: 20, Issue:2 Topics: Adolescent; Adult; After-Hours Care; Aged; Anti-Bacterial Agents; Bronchitis; Child; Child, Preschool; Cystitis; Databases, Factual; Drug Prescriptions; Female; Guideline Adherence; Humans; Infant; Middle Aged; Netherlands; Otitis Media; Pneumonia, Bacterial; Practice Guidelines as Topic; Primary Health Care; Quality Indicators, Health Care; Quinolones; Sinusitis; Tonsillitis; Young Adult	2014
Characterization and Genomic Analysis of Quinolone-Resistant Delftia sp. 670 Isolated from a Patient Who Died from Severe Pneumonia. Current microbiology, 2015, Volume: 71, Issue:1 Topics: Anti-Bacterial Agents; China; Delftia; DNA, Bacterial; Drug Resistance, Bacterial; Fatal Outcome; Genome, Bacterial; Gram-Negative Bacterial Infections; Humans; Molecular Sequence Data; Phylogeny; Pneumonia, Bacterial; Quinolones; Sequence Analysis, DNA; Sequence Homology; Sputum	2015
Community-acquired pneumonia. Seminars in respiratory and critical care medicine, 2009, Volume: 30, Issue:2 Topics: Community-Acquired Infections; Europe; Humans; Pneumococcal Vaccines; Pneumonia, Bacterial; Practice Guidelines as Topic; Quinolones; United States	2009
[A case of hospital-acquired pneumonia caused by intermediately susceptible carbapenem Acinetobacter baumannii]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2010, Volume: 84, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Carbapenems; Cross Infection; Humans; Male; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Quinolones	2010
Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:11 Topics: Adult; Age Factors; Anti-Bacterial Agents; beta-Lactams; China; Community-Acquired Infections; Female; Humans; Legionella pneumophila; Macrolides; Male; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Viral; Quinolones; Sputum; Streptococcus pneumoniae; Treatment Outcome	2010
Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia. The European respiratory journal, 2011, Volume: 37, Issue:6 Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Europe; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Piperacillin; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Quinolones; Respiration, Artificial; Severity of Illness Index; Treatment Outcome	2011
In vivo antibacterial activity of nemonoxacin, a novel non-fluorinated quinolone. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:11 Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Male; Mice; Microbial Sensitivity Tests; Pneumonia, Bacterial; Quinolones; Treatment Outcome; Urinary Tract Infections	2010
A bacterial cell to cell signal in the lungs of cystic fibrosis patients. FEMS microbiology letters, 2002, Sep-24, Volume: 215, Issue:1 Topics: Bronchoalveolar Lavage Fluid; Cystic Fibrosis; Humans; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Signal Transduction; Sputum	2002
In vitro activity of garenoxacin against recent clinical isolates of Chlamydia pneumoniae. International journal of antimicrobial agents, 2003, Volume: 21, Issue:6 Topics: Adult; Anti-Infective Agents; Canada; Chlamydophila Infections; Chlamydophila pneumoniae; Community-Acquired Infections; Fluoroquinolones; Humans; Indoles; Japan; Microbial Sensitivity Tests; Pneumonia, Bacterial; Quinolones; United States	2003
[Antibiotic therapy in routine medical care: progress in diagnosis of and therapy for bacterial infections (discussion)]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2006, Nov-10, Volume: 95, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Infections; Biomarkers; C-Reactive Protein; Drug Resistance, Multiple, Bacterial; Humans; Inpatients; Methicillin Resistance; Molecular Diagnostic Techniques; Outpatients; Pneumonia, Bacterial; Practice Guidelines as Topic; Pseudomonas aeruginosa; Quinolones; Staphylococcal Infections	2006
Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission. Respiratory medicine, 2007, Volume: 101, Issue:9 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Epidemiologic Methods; Female; Guideline Adherence; Humans; Length of Stay; Macrolides; Male; Middle Aged; Patient Readmission; Pneumonia, Bacterial; Practice Guidelines as Topic; Prognosis; Quinolones; Severity of Illness Index; Spain; Treatment Outcome	2007
Treatment costs associated with community-acquired pneumonia by community level of antimicrobial resistance. The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:5 Topics: Adult; Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Female; Health Care Costs; Humans; Macrolides; Male; Middle Aged; Pneumonia, Bacterial; Quinolones; Retrospective Studies; Treatment Outcome	2008
Protective effects of sparfloxacin in experimental pneumonia caused by Chlamydia pneumoniae in leukopenic mice. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:8 Topics: Animals; Anti-Infective Agents; Chlamydia Infections; Chlamydophila pneumoniae; Female; Fluoroquinolones; Leukopenia; Lung; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumonia, Bacterial; Quinolones	1994
[Fluoroquinolones in antimicrobial therapy and prophylaxis in surgery]. Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti, 1995, Volume: 74, Issue:6 Topics: 4-Quinolones; Anti-Infective Agents; Ceftazidime; Cross Infection; Drug Resistance, Microbial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pefloxacin; Pneumonia, Bacterial; Postoperative Complications; Premedication; Quinolones; Wounds and Injuries	1995
In vitro and in vivo antibacterial activities of CS-940, a new 6-fluoro-8-difluoromethoxy quinolone. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:5 Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Evaluation, Preclinical; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Naphthyridines; Piperazines; Pneumonia, Bacterial; Quinolones	1996
In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:6 Topics: Animals; Anti-Infective Agents; Chlamydia; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Chlamydophila psittaci; Disease Models, Animal; Fluoroquinolones; Gatifloxacin; Male; Mice; Microbial Sensitivity Tests; Piperazines; Pneumonia, Bacterial; Quinolones	1997
Respiratory infection in lipid-fed rabbits enhances sudanophilia and the expression of VCAM-1. The American journal of pathology, 1997, Volume: 151, Issue:4 Topics: Animals; Anti-Infective Agents; Aorta, Thoracic; Arteriosclerosis; Azo Compounds; Cell Count; Cholesterol; Coloring Agents; Dietary Fats; Endothelium, Vascular; Enrofloxacin; Fluoroquinolones; Pasteurella Infections; Pasteurella multocida; Pneumonia, Bacterial; Quinolones; Rabbits; Specific Pathogen-Free Organisms; Vascular Cell Adhesion Molecule-1	1997
Safety profile of sparfloxacin, a new fluoroquinolone antibiotic. Clinical therapeutics, 1999, Volume: 21, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bronchitis; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Data Interpretation, Statistical; Female; Fluoroquinolones; Heart Rate; Humans; Male; Middle Aged; Photosensitivity Disorders; Pneumonia, Bacterial; Quinolones; Sinusitis; Skin Diseases, Bacterial	1999
Dual infection with Pneumocystis carinii and Pasteurella pneumotropica in B cell-deficient mice: diagnosis and therapy. Comparative medicine, 2000, Volume: 50, Issue:1 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; B-Lymphocytes; Cesarean Section; DNA, Bacterial; Enrofloxacin; Feces; Female; Fluoroquinolones; Immunohistochemistry; Lung; Male; Mice; Mice, Inbred ICR; Pasteurella; Pasteurella Infections; Pneumocystis; Pneumonia, Bacterial; Pneumonia, Pneumocystis; Polymerase Chain Reaction; Quinolones; Rodent Diseases; Trimethoprim, Sulfamethoxazole Drug Combination	2000
Relation of antibiotic use to risk of myocardial infarction in the general population. The American journal of cardiology, 2002, Jan-01, Volume: 89, Issue:1 Topics: Anti-Bacterial Agents; Cephalosporins; Chlamydophila Infections; Chlamydophila pneumoniae; Databases, Factual; Female; Humans; Insurance; Macrolides; Male; Medical Records; Middle Aged; Myocardial Infarction; Penicillins; Pneumonia, Bacterial; Proportional Hazards Models; Quinolones; Retrospective Studies; Risk Factors; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; United States	2002